Significant reduction in time and cost for various tests based on alternative methods to experimental animals!
Our company exclusively uses myeloid cells derived from iPS cells, allowing for highly accurate measurements of neurotransmitters and cytokines induced by stimulation. The reliability of test results and the flexibility of evaluation design have dramatically increased, significantly reducing measurement time and costs. This has led to a groundbreaking evaluation service that contributes to faster product development. Please feel free to contact us if you have any requests. 【About Blood Cells】 ■ Dendritic cells produced using regenerative medicine technology from healthy human cells: "Mylc" blood cells ■ These "Mylc" blood cells, which possess the same genes and are controlled in an undifferentiated state (immature) before external stimulation, provide pure and clear responses to stimuli in tests, resulting in highly reliable test results. ■ The responses are very close to human in vivo reactions, and there are no issues with the reproducibility of results. *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【About Testing Methods】 ■ Skin Sensitization Test - Similar results to model cells (LLNA) are obtained with the standard 10 compounds (P1-N10) of the h-CLAT method. - Complicated confirmations like those required for the h-CLAT method are unnecessary, significantly reducing time and costs. ■ Pyrogenicity Test - "Mylc," which shows a response closer to that of a living organism compared to model cells (such as Mono-Mac-6) used in alternative methods for experimental animals, has excellent sensitivity and stability for sensitization. *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
Our company is headquartered at the "Kyoto University Katsura Venture Plaza," which aims to create new businesses utilizing seeds and intellectual property from Kyoto University. We produce and supply homogeneous and high-precision "human blood cells" in the required quantities through regenerative medicine technology, significantly improving the efficiency of research on infectious diseases and the evaluation of efficacy and safety for pharmaceuticals and functional materials. We also offer "evaluation kits" for sale and "evaluation contract services." Please feel free to contact us if you have any inquiries.